The Trump administration has launched a sweeping effort to restrict gender-affirming care for minors, arguing that such treatment is unsafe and irreversible.
The new policy announcements from the Department of Health and Human Services (HHS) would sharply limit, and potentially end, access to puberty blockers, hormone therapy and related care for transgender children across the United States.
